Home

Jennifer Evans Stacey

CIK 1321326 · Chief Legal Officer · last filed 2026-06-26

Jennifer Evans Stacey is a Chief Legal Officer who has filed 28 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for CNTX, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$745.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $361.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$361.6K

Companies

5

Total Filings

28

Lifetime Open-Market Net

-$745.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CNTX Director — $0.59 — $0 5 2026-06-26
NEOG Chief Legal Officer 39,349 $9.19 $361.6K $0 1 2026-05-04
GRTX See Remarks — $17.60 — $0 3 2023-02-28
ANTARES PHARMA, INC. (ATRS) Delisted SVP, General Counsel & Secty 92,042 $5.59 $514.5K $0 2 2015-06-01
AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted Executive VP & General Counsel 16,878 — — -$745.2K 17 2011-04-04

Recent Filings

28 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-26 CNTX Grant (A) — $0 EDGAR
2026-05-04 NEOG Grant (A) +39,349 $375.0K EDGAR
2025-06-12 CNTX Grant (A) — $0 EDGAR
2024-06-14 CNTX Grant (A) — $0 EDGAR
2023-05-31 CNTX Grant (A) — $0 EDGAR
2023-02-28 GRTX Grant (A) — $0 EDGAR
2022-06-03 CNTX Grant (A) — $0 EDGAR
2022-03-02 GRTX Grant (A) — $0 EDGAR
2021-10-12 GRTX Grant (A) — $0 EDGAR
2015-06-01 ANTARES PHARMA, INC. (ATRS) Delisted Mixed +67,770 -$5.4K EDGAR
Showing 1–10 of 28
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.